| The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer RM Bremnes, T Dønnem, S Al-Saad, K Al-Shibli, S Andersen, R Sirera, ... Journal of thoracic oncology 6 (1), 209-217, 2011 | 729 | 2011 |
| Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood RM Bremnes, C Camps, R Sirera Lung cancer 51 (2), 143-158, 2006 | 462 | 2006 |
| The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer RM Bremnes, K Al-Shibli, T Donnem, R Sirera, S Al-Saad, S Andersen, ... Journal of Thoracic Oncology 6 (4), 824-833, 2011 | 373 | 2011 |
| FGFR a promising druggable target in cancer: Molecular biology and new drugs R Porta, R Borea, A Coelho, S Khan, A Araújo, P Reclusa, T Franchina, ... Critical reviews in oncology/hematology 113, 256-267, 2017 | 242 | 2017 |
| Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? RM Bremnes, R Sirera, C Camps Lung cancer 49 (1), 1-12, 2005 | 191 | 2005 |
| Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017 | 176 | 2017 |
| Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates JV Bagan, Y Jiménez, D Gómez, R Sirera, R Poveda, C Scully Oral oncology 44 (11), 1088-1089, 2008 | 141 | 2008 |
| Inmunología, estrés, depresión y cáncer R Sirera, PT Sánchez, C Camps Psicooncología 3 (1), 35, 2006 | 120 | 2006 |
| Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer R Sirera, RM Bremnes, A Cabrera, E Jantus-Lewintre, E Sanmartín, ... Journal of Thoracic Oncology 6 (2), 286-290, 2011 | 107 | 2011 |
| Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer A Herreros-Pomares, JD de-Maya-Girones, S Calabuig-Fariñas, R Lucas, ... Cell death & disease 10 (9), 660, 2019 | 81 | 2019 |
| Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? C Camps, R Sirera, R Bremnes, A Blasco, E Sancho, P Bayo, MJ Safont, ... Lung cancer 50 (3), 339-346, 2005 | 80 | 2005 |
| Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC E Jantus-Lewintre, E Sanmartín, R Sirera, A Blasco, JJ Sanchez, M Tarón, ... Lung Cancer 74 (2), 326-331, 2011 | 75 | 2011 |
| The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients C Camps, E Jantus-Lewintre, A Cabrera, A Blasco, E Sanmartín, ... Lung Cancer 72 (3), 365-369, 2011 | 69 | 2011 |
| Importance of quality of life in patients with non–small-cell lung cancer C Camps, N del Pozo, A Blasco, P Blasco, R Sirera Clinical lung cancer 10 (2), 83-90, 2009 | 60 | 2009 |
| Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor C Soza-Ried, E Bustamante, C Caglevic, C Rolfo, R Sirera, H Marsiglia Critical Reviews in Oncology/Hematology 139, 128-133, 2019 | 53 | 2019 |
| Estrés, depresión, inflamación y dolor PT Sánchez, R Sirera, G Peiró, F Palmero REME 11 (28), 1-15, 2008 | 45 | 2008 |
| Exosomes genetic cargo in lung cancer: a truly Pandora’s box P Reclusa, R Sirera, A Araujo, M Giallombardo, A Valentino, L Sorber, ... Translational lung cancer research 5 (5), 483, 2016 | 44 | 2016 |
| Anorexia–cachexia syndrome in cancer: implications of the ubiquitin–proteasome pathway C Camps, V Iranzo, RM Bremnes, R Sirera Supportive care in cáncer 14, 1173-1183, 2006 | 43 | 2006 |
| Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers M Usó, E Jantus-Lewintre, RM Bremnes, S Calabuig, A Blasco, E Pastor, ... Oncotarget 7 (33), 52849, 2016 | 41 | 2016 |
| Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels R Sirera, A Salvador, I Roldan, R Talens, A González‐Molina, M Rivera European journal of heart failure 5 (1), 27-31, 2003 | 40 | 2003 |
Carlos CampsProfessor MedicineVerified email at gva.es
